(1S,5R)-7-[[2-(benzenesulfonylmethyl)phenyl]methyl]-3-oxa-7,9-diazabicyclo[3.3.2]decan-10-one
C21H24N2O4S — CID 155919211
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1S,5R)-7-[[2-(benzenesulfonylmethyl)phenyl]methyl]-3-oxa-7,9-diazabicyclo[3.3.2]decan-10-one
(1S,5R)-7-[[2-(benzenesulfonylmethyl)phenyl]methyl]-3-oxa-7,9-diazabicyclo[3.3.2]decan-10-one (PubChem CID 155919211) has the molecular formula C21H24N2O4S and a molecular weight of 400.50 g/mol. Its IUPAC name is (1S,5R)-7-[[2-(benzenesulfonylmethyl)phenyl]methyl]-3-oxa-7,9-diazabicyclo[3.3.2]decan-10-one.
Molecular Properties
| Compound Name | (1S,5R)-7-[[2-(benzenesulfonylmethyl)phenyl]methyl]-3-oxa-7,9-diazabicyclo[3.3.2]decan-10-one |
|---|---|
| PubChem CID | 155919211 |
| Molecular Formula | C21H24N2O4S |
| Molecular Weight | 400.50 g/mol |
| Exact Mass | 400.15 |
| IUPAC Name | (1S,5R)-7-[[2-(benzenesulfonylmethyl)phenyl]methyl]-3-oxa-7,9-diazabicyclo[3.3.2]decan-10-one |
| SMILES | O=C1N[C@@H]2COC[C@H]1CN(Cc1ccccc1CS(=O)(=O)c1ccccc1)C2 |
| InChI | InChI=1S/C21H24N2O4S/c24-21-18-11-23(12-19(22-21)14-27-13-18)10-16-6-4-5-7-17(16)15-28(25,26)20-8-2-1-3-9-20/h1-9,18-19H,10-15H2,(H,22,24)/t18-,19+/m1/s1 |
| InChIKey | ZKWDUKJCUCQOGI-MOPGFXCFSA-N |
| XLogP | 1.61 |
| TPSA | 75.71 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 400.50 |
| LogP ≤ 5 | 1.61 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155919211 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.